e-learning
resources
ERJ
2003
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Murine models of asthma
Kips J.C., Anderson G.P., Fredberg J.J., Herz U., Inman M.D., Jordana M., Kemeny D.M., Lotvall J., Pauwels R.A., Plopper C.G., Schmidt D., Sterk P.J., Van Oosterhout A.J.M., Vargaftig B.B., Chung K.F.
Source:
Eur Respir J 2003; 22: 374-382
Journal Issue:
August
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Kips J.C., Anderson G.P., Fredberg J.J., Herz U., Inman M.D., Jordana M., Kemeny D.M., Lotvall J., Pauwels R.A., Plopper C.G., Schmidt D., Sterk P.J., Van Oosterhout A.J.M., Vargaftig B.B., Chung K.F.. Murine models of asthma. Eur Respir J 2003; 22: 374-382
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Murine models of asthma
Source: Guideline 2003
Year: 2003
IL-13-dependent C3a-release in a murine model of allergic asthma
Source: Annual Congress 2005 - Airway epithelial cells in asthma and COPD
Year: 2005
ST2 gene knockout attenuates allergic airways disease
Source: Annual Congress 2006 - Immunological mechanisms in cell recruitment to the lungs
Year: 2006
Models of asthma employing ovalbumin in rats and mice: similarities and differences compared with patient asthma
Source: Annual Congress 2005 - PG11 - Experimental models for COPD and asthma
Year: 2005
Role of CD163 in human fatal asthma and murine asthma model.
Source: International Congress 2018 – Physiological and biological insights in asthma
Year: 2018
Experimental specific immunotherapy with timpol decreases allergic sensitization and airway inflammation in murine model of bronchial asthma
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
Analysis of mucus production in mouse models of allergic asthma
Source: Annual Congress 2010 - Asthma: basic science and clinical studies
Year: 2010
Pharmacological characterization of the protective effect of benralizumab against airway hyperresponsiveness in a human ex vivo model of severe asthma
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019
The effect of lipopolysaccharide-contaminated ovalbumin on airway inflammation and remodeling in a chronic murine asthma model
Source: Annual Congress 2013 –Murine models of lung immunology
Year: 2013
Treatment with gp120 reduces AHR and airway inflammation in a humanized mouse model of asthma bronchiale
Source: Annual Congress 2010 - Asthma: clinical aspects and treatment
Year: 2010
Deficiency of MMP-19 promotes allergen-induced eosinophil burden and airway responsiveness in mice
Source: Annual Congress 2007 - Regulation of allergic airway inflammation in animal models of asthma
Year: 2007
Development of a mouse model of airway inflammation and remodeling in experimental asthma
Source: Annual Congress 2007 - Mouse models of allergic airway inflammation
Year: 2007
Opioid-neurotensin hybrid influences pulmonary inflammatory process in murine model of non-atopic asthma.
Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology
Year: 2017
Obesity enhances allergen-induced airway inflammation in a murine model of asthma
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019
Plasma cells in the airways express neurotrophins and neurotrophin-receptors in a mouse model of chronic allergic asthma
Source: Annual Congress 2007 - Regulation of allergic airway inflammation in animal models of asthma
Year: 2007
Respiratory viral infections as promoters of allergic sensitization and asthma in animal models
Source: Eur Respir J 2002; 19: 341-349
Year: 2002
Airway hyperresponsiveness in asthma: lessons from in vitro model systems and animal models
Source: Eur Respir J 2008; 32: 487-502
Year: 2008
Role of mouse mast cell protease 4 in a murine model of allergic asthma
Source: Annual Congress 2007 - Regulation of allergic airway inflammation in animal models of asthma
Year: 2007
Pharmacological characterization of the protective effect of mepolizumab against airway hyperresponsiveness in a human ex vivo model of severe asthma
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019
PDE-4-inhibitor rolipram supports treg-mediated suppression in a murine model of allergic airway disease
Source: Annual Congress 2008 - Risk factors for asthma versus asthma control
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept